semaglutide cardiovascular news 🔴Cardiovascular outcomes with by severity of chronic kidney disease in type 2 diabetes: the FLOW trial⤵️ 🔹Semaglutide significantly reduced the risk of CV death/MI/stroke regardless of baseline CKD severity in participants Cardiovascular risk reduction with once-weekly

The Importance of Proper Medical Monitoring Effective TRT requires ongoing laboratory monitoring to ensure safety and optimize results

GLP-1 by the numbers 8-10% of US adults already on a GLP-1 30-35% of consumers say theyre interested (PwC) 30 million projected global users by 2030 $126-$150 billion projected size of the obesity drug market by 2030 Household snack spend falls 5-11% within six months of a GLP-1 start Reformulation or retreat Not all players are on the defensive

We prescribe leading GLP-1 medications Tirzepatide (Mounjaro/Zepbound) and Semaglutide (Ozempic/Wegovy) and provide full virtual management with medication shipped directly to your door

Even so, these products remain widely promoted online

IGF-1 LR3 is a direct IGF-1 receptor agonist it bypasses the pituitary and liver entirely and acts directly on IGF-1 receptors in muscle, fat, and connective tissue